Cardiovascular Systems Performance
| CSIIDelisted Stock | USD 20.00 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.9, which signifies possible diversification benefits within a given portfolio. Cardiovascular Systems returns are very sensitive to returns on the market. As the market goes up or down, Cardiovascular Systems is expected to follow. Cardiovascular Systems right now shows a risk of 0.0%. Please confirm Cardiovascular Systems treynor ratio, as well as the relationship between the downside variance and kurtosis , to decide if Cardiovascular Systems will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Cardiovascular Systems has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong forward indicators, Cardiovascular Systems is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders. ...more
| Begin Period Cash Flow | 71.1 M | |
| Total Cashflows From Investing Activities | 22.2 M |
Cardiovascular |
Cardiovascular Systems Relative Risk vs. Return Landscape
If you would invest 2,000 in Cardiovascular Systems on September 14, 2024 and sell it today you would earn a total of 0.00 from holding Cardiovascular Systems or generate 0.0% return on investment over 90 days. Cardiovascular Systems is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Cardiovascular, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Cardiovascular Systems Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cardiovascular Systems' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Cardiovascular Systems, and traders can use it to determine the average amount a Cardiovascular Systems' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| CSII |
Based on monthly moving average Cardiovascular Systems is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cardiovascular Systems by adding Cardiovascular Systems to a well-diversified portfolio.
Cardiovascular Systems Fundamentals Growth
Cardiovascular Stock prices reflect investors' perceptions of the future prospects and financial health of Cardiovascular Systems, and Cardiovascular Systems fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cardiovascular Stock performance.
| Return On Equity | -0.15 | |||
| Return On Asset | -0.0756 | |||
| Profit Margin | (0.16) % | |||
| Operating Margin | (0.16) % | |||
| Current Valuation | 466.13 M | |||
| Shares Outstanding | 42.2 M | |||
| Price To Earning | 724.24 X | |||
| Price To Book | 2.43 X | |||
| Price To Sales | 2.51 X | |||
| Revenue | 236.22 M | |||
| EBITDA | (29.96 M) | |||
| Cash And Equivalents | 159.83 M | |||
| Cash Per Share | 3.90 X | |||
| Total Debt | 22.15 M | |||
| Debt To Equity | 0.09 % | |||
| Book Value Per Share | 5.70 X | |||
| Cash Flow From Operations | (24.27 M) | |||
| Earnings Per Share | (0.96) X | |||
| Total Asset | 322.68 M | |||
| Retained Earnings | (320 M) | |||
| Current Asset | 104.88 M | |||
| Current Liabilities | 35.5 M | |||
About Cardiovascular Systems Performance
By evaluating Cardiovascular Systems' fundamental ratios, stakeholders can gain valuable insights into Cardiovascular Systems' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Cardiovascular Systems has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Cardiovascular Systems has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in Saint Paul, Minnesota. Cardiovascular Syst operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 725 people.Things to note about Cardiovascular Systems performance evaluation
Checking the ongoing alerts about Cardiovascular Systems for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cardiovascular Systems help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cardiovascular Systems is not yet fully synchronised with the market data | |
| Cardiovascular Systems has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 236.22 M. Net Loss for the year was (36.93 M) with profit before overhead, payroll, taxes, and interest of 172.78 M. | |
| Cardiovascular Systems currently holds about 159.83 M in cash with (24.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.9. | |
| Over 90.0% of the company shares are held by institutions such as insurance companies |
- Analyzing Cardiovascular Systems' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cardiovascular Systems' stock is overvalued or undervalued compared to its peers.
- Examining Cardiovascular Systems' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cardiovascular Systems' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cardiovascular Systems' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Cardiovascular Systems' stock. These opinions can provide insight into Cardiovascular Systems' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Consideration for investing in Cardiovascular Stock
If you are still planning to invest in Cardiovascular Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cardiovascular Systems' history and understand the potential risks before investing.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |